Therapeutic Drug Could Help Keep COVID-19 Patients Off Ventilators

The video discusses the impact of COVID-19 on the lungs, leading to pneumonia and the need for ventilators. It highlights the limited availability of ventilators and introduces a potential therapeutic drug being tested by Airway Therapeutics. This drug, an engineered protein, aims to reduce lung inflammation and infection. Currently in clinical trials for another lung disease, the drug's application for COVID-19 is uncertain due to manufacturing challenges.

What new insight or understanding did you gain from this video?